Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · IEX Real-Time Price · USD
6.84
-0.10 (-1.44%)
Jul 2, 2024, 4:00 PM EDT - Market closed

MRVI Revenue

Maravai LifeSciences Holdings had revenue of $274.10M in the twelve months ending March 31, 2024, down -61.81% year-over-year. Revenue in the quarter ending March 31, 2024 was $64.18M, a -18.79% decrease year-over-year. In the year 2023, Maravai LifeSciences Holdings had annual revenue of $288.95M, a decrease of -67.28%.

Revenue (ttm)
$274.10M
Revenue Growth
-61.81%
P/S Ratio
3.31
Revenue / Employee
$421,691
Employees
650
Market Cap
908.56M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023288.95M-594.06M-67.28%
Dec 31, 2022883.00M83.76M10.48%
Dec 31, 2021799.24M515.14M181.33%
Dec 31, 2020284.10M140.96M98.48%
Dec 31, 2019143.14M19.31M15.59%
Dec 31, 2018123.83M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
OPKO Health 799.60M
Avanos Medical 680.10M
Cronos Group 93.03M
Liquidia 15.97M
Autolus Therapeutics 10.50M
ARS Pharmaceuticals 10.00K
Revenue Rankings